Jeantet advises Omnes in connection with the fundraising of Redman

 

Paris, January 24, 2023 – Jeantet has advised Omnes, a leading private equity and facility specialist and ESG player, in the acquisition of a minority interest in the Redman Group, founded in 2007 by Matthias Navarro and Nicolas Ponson, in connection with the raising of more than €30 million in equity and debt.

Through CEP2, its fund for sustainable cities (“Ville Durable”), Omnes will provide Redman with substantial financial resources in the form of a minority participating interest in the Group’s capital and the creation of a development fund. These resources will enable Redman to accelerate its growth in its low-carbon real estate development activities.

As a leading player in the field of urban rehabilitation and requalification for many years, Redman is acquiring additional capacity for action through the creation of a development fund designed to carry assets to be restructured. Therefore, Redman and Omnes are working towards a goal of less than 2° Celsius and in line with the Paris Agreements, to accelerate the decarbonization of existing buildings, using the group’s multi-product expertise.

With nearly 15 years of experience in the real estate industry, Redman Group is a company focused on developing low-carbon and inclusive cities. The Group operates through three business lines: real estate development (the Group’s historical business) for the tertiary, residential and hospitality sectors, investor-operator in the hotel sector and land investor for the territories through its real estate company Essentiel. It operates throughout France with offices in Paris, Lyon, Bordeaux, Aix-en-Provence and Montpellier, with nearly 70 employees in development and more than 170 throughout the Group.

The only French developer with the BCorp label, Redman will have sales of over €100 million in 2023 and, thanks to this fundraising, should exceed €200 million in the next three years. This transaction will allow the group to expand its presence throughout France.

Omnes is a major player in private equity and facilities. With more than €5 billion of assets under management, Omnes provides companies with the equity capital they need to grow through its four core businesses: Venture Capital, Expansion Capital & LBO, Infrastructure and Co-investment. Omnes is 100% owned by its employees. Omnes is committed to ESG issues. The company has created the Omnes Foundation in favor of children and youth. It is a signatory of the United Nations Principles for Responsible Investment (PRI).

Our last press releases

Jeantet advises LIDL on the acquisition of 19 supermarkets under the AUCHAN brand

Paris, July 25, 2025 – Jeantet advised the retail chain Lidl on the planned acquisition of 19 supermarkets currently operated under the Auchan banner. Auchan’s employee representative bodies are currently being consulted regarding the contemplated transaction. The completion of the deal remains subject to the fulfilment of several conditions, including clearance from the French Competition […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises a consortium of banks on the financing of the acquisition and refurbishment of hotel Paris-Charles de Gaulle by LUITEN VAN DER VALK GROUP

Paris, July 23, 2025 – Jeantet has advised ING BANK N.V., COÖPERATIEVE RABOBANK U.A. and ABN AMRO BANK N.V., in connection with a structured secured financing to LUITEN VAN DER VALK hotel and leisure group for the acquisition of the SHIR, a company owning the Atrium Hotel & Conference Centre Paris – Charles de Gaulle, […]

Paris | BANK-FINANCE-REGULATORY

+

Jeantet advises DREAMPATH DIAGNOSTICS on the acquisition of a stake by SUMMIT PARTNERS

Paris, July 16, 2025 – Jeantet advised Dreampath Diagnostics, a group specializing in automation and traceability of anatomical pathology samples, on Summit Partners’ acquisition of a minority stake. The transaction aims to accelerate Dreampath Diagnostics’ international growth and strengthen its offering of solutions for digitizing laboratory processes. Founded in 2012, the Dreampath Diagnostics group offers […]

Paris

+

Jeantet advises COGELEC and the shareholders of COGELEC DEVELOPPEMENT, majority shareholder of COGELEC, in the context of the proposed acquisition of COGELEC DEVELOPPEMENT by LEGRAND, prior to the filing of a simplified tender offer on COGELEC shares

Paris, July 11, 2025 – Jeantet advises Cogelec (a company listed on the Euronext Growth Paris market), French specialist of the housing access control, as well as the shareholders of Cogelec Développement, indirect majority shareholder of Cogelec, in the context of the contemplated acquisition of the Cogelec Développement shares by Legrand (a company listed on […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advises Oxylabs in connection with its acquisition of Scrapingbee

Paris, July 4, 2025 – Jeantet advised Oxylabs, one of the market-leading companies in web scraping solutions, in connection with its acquisition of ScrapingBee, a French fast-growing web scraping company known for its developer-friendly solutions. Through this strategic acquisition, Oxylabs significantly expands the Oxylabs group’s ecosystem as well as its target clientele, now addressing direct […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises AEQUITA on the acquisition of european olefins et polyolefins assets from chemicals group LYONDELLBASELL

Paris, June 27, 2025 – Jeantet acted as French legal counsel to AEQUITA SE & Co. KGaA, a global industrial group headquartered in Munich, in connection with the signing of an agreement and entry into exclusive negotiations to acquire four European olefins and polyolefins assets from chemicals group LyondellBasell. The transaction covers plants located in […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet assists Melvan in its €25 million fundraising to accelerate its development in France

Paris, June 26, 2025 – Jeantet assisted Melvan, a multi-technology renewable energy producer and developer, in opening its capital to a consortium of investors composed of Bpifrance, through its France Investissement Énergie Environnement 2 fund, IDIA Capital Investissement, through its Crédit Agricole Energie & Economie Bas Carbone I fund, and a pool of investors from […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | PUBLIC LAW – PUBLIC CONTRACTS | ENERGY AND NATURAL RESOURCES LAW | BANKING AND FINANCE LAW | EMPLOYMENT

+

Ginestié and Jeantet form a strategic partnership

Paris, June 20, 2025 – Jeantet and Ginestié Paley-Vincent announce the entry into a strategic partnership, effective October 1, 2025. This alliance is based on a common vision of the legal profession, its evolution, and its requirements. This partnership represents a significant milestone in the development of Ginestié Paley-Vincent, which has decided to join forces […]

Paris

+

JEANTET ASSISTS SIRIUS SPACE SERVICES IN ITS ACQUISITION OF S.E.R.M FROM THE FIVES GROUP

Paris, June 19, 2025 – Jeantet advises Sirius Space Services, a player in the space sector, on the acquisition of S.E.R.M (Société d’Études et de Réalisations Mécaniques), a historic precision machining site, accompanied by a strategic partnership with the Fives group and its subsidiary AddUp, a specialist in metal additive manufacturing. With this strategic acquisition, […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

JEANTET ADVISES CENTREON IN CONNECTION WITH ITS ACQUISITION OF QUANTA IO

Paris, June 13, 2025 – Jeantet is advising Centreon, a trusted partner in digital performance monitoring, in connection with its acquisition of Quanta.io, a French software company renowned for its expertise in Web Performance and Green IT. Through this strategic acquisition, Centreon becomes the only private and independent vendor to offer an end-to-end observability platform […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises CUREETY in connection with its acquisition of CONTINUUM PLUS SANTÉ

Paris, June 6, 2025 – Jeantet is advising Cureety in connection with its acquisition of the company Continuum Plus Santé, both specializing on remote monitoring for cancer patients.  Through this acquisition, Cureety consolidates its leadership position in remote monitoring in oncology, particularly through better management of the “Hospital-City-Home” care pathway by enabling the involvement of […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+